To maintain normal proliferation and suppressor function, Tregs would metabolize LA, rather than glucose, via monocarboxylate transporter 1 (MCT1).[19] By deletion of MCT1 of Tregs, tumor growth slows, and antitumor response increases. The gene discussed is SLC16A1; the disease is neoplasm.